Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
88%(7 trials)

Phase Distribution

Ph not_applicable
5
56%
Ph phase_3
4
44%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution9 total trials
Phase 3Large-scale testing
4(44.4%)
N/ANon-phased studies
5(55.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(8)

Detailed Status

Completed8
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 34 (44.4%)
N/A5 (55.6%)

Trials by Status

completed889%
not_yet_recruiting111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
COMBINATION PRODUCT
Total Trials
9